AERI Chart
- 52-Week Range: $5.64 - $18.84
- Market Capitalization: $331.12M
- Short Percentage: 0%
- Target Price: $18.67
- Shares Outstanding: 48.62M
- Next Earnings: Feb 24
Catalysts
CategoryCatalyst
Earnings
AERI released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Aerie Pharmaceuticals, Inc. (AERI) CEO Raj Kannan on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 24th
- Aerie Pharmaceuticals Appoints Gary Sternberg, M.D., M.B.A. as Chief Medical OfficerBusiness Wire | February 24th
- Aerie Pharmaceuticals Reports Inducement Grant to Chief Executive Officer Under Nasdaq Listing Rule 5635(c)(4)Business Wire | December 22nd
- Aerie Pharmaceuticals Appoints Raj Kannan as Chief Executive OfficerBusiness Wire | December 16th
- Aerie Pharmaceuticals to Participate in Upcoming Investor ConferencesBusiness Wire | November 9th
- Aerie Pharmaceuticals' (AERI) Management on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 7th
Company Info
Website: https://www.aeriepharma.com
Address: 4301 Emperor Boulevard, Durham, NC, United States, 27703
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 376
Address: 4301 Emperor Boulevard, Durham, NC, United States, 27703
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 376
$AERI very normal lol sike
$AERI looks like a loading
$AERI we going up from here
$AERI R-E-L-A-X Green is coming
$AERI where’s the WSB guys at? Still sleeping?
$AERI When in doubt...